During the past decade, Ankara Universitesi Tip Fakultesi Cebeci Hastanesi conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 11 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 9 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ankara Universitesi Tip Fakultesi Cebeci Hastanesi" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Bayer" with 3 trials sponsored and "Diskapi Teaching and Research Hospital" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara Universitesi Tip Fakultesi Cebeci Hastanesi" #1 collaborator was "Janssen Biotech, Inc., including Johnson & Johnson" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator, "Pharmacyclics LLC." with 1 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ankara Universitesi Tip Fakultesi Cebeci Hastanesi" are "Blood Transfusion" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials), "Multiple Myeloma" (2 trials), "Urinary Bladder Neoplasms" (2 trials) and "Abiraterone Acetate" (1 trials). Many other conditions were trialed in "Ankara Universitesi Tip Fakultesi Cebeci Hastanesi" in a lesser frequency.

Most popular intervention types in "Ankara Universitesi Tip Fakultesi Cebeci Hastanesi" are "Drug" (23 trials), "Biological" (6 trials), "Other" (4 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Daratumumab" (3 trials), "Abemaciclib" (2 trials), "Blood transfusion" (2 trials) and "Cetrelimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ankara Universitesi Tip Fakultesi Cebeci Hastanesi" are 24 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ankara Universitesi Tip Fakultesi Cebeci Hastanesi". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Ankara Universitesi Tip Fakultesi Cebeci Hastanesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ankara Universitesi Tip Fakultesi Cebeci Hastanesi, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".